SUPERNUS PHARMACEUTICALS, INC. Shares Outstanding (Cover Page)
SUPERNUS PHARMACEUTICALS, INC. (SUPN) had Shares Outstanding (Cover Page) of 58.13 million shares as of 2026-07-28, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-03
- 2026-07-28: Entity Common Stock, Shares Outstanding 58.13M shares.
- 2026-04-28: Entity Common Stock, Shares Outstanding 58.04M shares.
- 2026-02-24: Entity Common Stock, Shares Outstanding 57.58M shares.
- 2025-10-29: Entity Common Stock, Shares Outstanding 57.34M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-28 | 58.13M shares 10-Q · filed 2026-08-03 |
| 2026-04-28 | 58.04M shares 10-Q · filed 2026-05-05 |
| 2026-02-24 | 57.58M shares 10-K · filed 2026-03-02 |
| 2025-10-29 | 57.34M shares 10-Q · filed 2025-11-06 |
| 2025-07-29 | 56.07M shares 10-Q · filed 2025-08-05 |
| 2025-04-29 | 55.99M shares 10-Q · filed 2025-05-06 |
| 2025-02-18 | 55.81M shares 10-K · filed 2025-02-25 |
| 2024-10-30 | 55.22M shares 10-Q · filed 2024-11-04 |
| 2024-07-30 | 55.11M shares 10-Q · filed 2024-08-06 |
| 2024-05-01 | 54.97M shares 10-Q · filed 2024-05-08 |
| 2023-11-01 | 54.63M shares 10-Q · filed 2023-11-08 |
| 2023-08-01 | 54.59M shares 10-Q · filed 2023-08-08 |
| 2023-05-03 | 54.48M shares 10-Q · filed 2023-05-09 |
| 2023-02-22 | 54.38M shares 10-K · filed 2023-03-09 |
| 2022-10-31 | 54.06M shares 10-Q · filed 2022-11-09 |
| 2022-08-01 | 53.50M shares 10-Q · filed 2022-08-08 |
| 2022-05-02 | 53.41M shares 10-Q · filed 2022-05-12 |
| 2022-03-30 | 53.39M shares 10-K · filed 2022-04-13 |
| 2021-11-01 | 53.18M shares 10-Q · filed 2021-11-05 |
| 2021-08-02 | 53.15M shares 10-Q · filed 2021-08-06 |
| 2021-04-30 | 53.02M shares 10-Q · filed 2021-05-07 |
| 2021-02-28 | 52.92M shares 10-K · filed 2021-03-08 |
| 2020-10-30 | 52.69M shares 10-Q · filed 2020-11-06 |
| 2020-07-31 | 52.66M shares 10-Q · filed 2020-08-17 |
| 2020-04-29 | 52.54M shares 10-Q · filed 2020-05-15 |
| 2020-02-13 | 52.53M shares 10-K · filed 2020-02-28 |
| 2019-10-31 | 52.46M shares 10-Q · filed 2019-11-08 |
| 2019-08-05 | 52.45M shares 10-Q · filed 2019-08-09 |
| 2019-05-01 | 52.38M shares 10-Q · filed 2019-05-10 |
| 2019-02-13 | 52.32M shares 10-K · filed 2019-03-01 |
| 2018-11-01 | 52.26M shares 10-Q · filed 2018-11-09 |
| 2018-08-03 | 52.21M shares 10-Q · filed 2018-08-09 |
| 2018-05-02 | 51.80M shares 10-Q · filed 2018-05-10 |
| 2018-02-19 | 51.54M shares 10-K · filed 2018-03-01 |
| 2017-10-31 | 51.26M shares 10-Q · filed 2017-11-09 |
| 2017-07-27 | 50.70M shares 10-Q · filed 2017-08-03 |
| 2017-05-02 | 50.28M shares 10-Q · filed 2017-05-09 |
| 2017-03-09 | 50.16M shares 10-K · filed 2017-03-16 |
| 2017-01-17 | 50.12M shares 10-Q/A · filed 2017-01-23 |
| 2016-07-29 | 49.51M shares 10-Q · filed 2016-08-05 |
| 2016-04-29 | 49.42M shares 10-Q · filed 2016-05-10 |
| 2016-02-29 | 49.40M shares 10-K · filed 2016-03-09 |
| 2015-10-30 | 48.92M shares 10-Q · filed 2015-11-09 |
| 2015-08-03 | 48.45M shares 10-Q · filed 2015-08-07 |
| 2015-05-04 | 47.76M shares 10-Q · filed 2015-05-06 |
| 2015-03-11 | 44.09M shares 10-K · filed 2015-03-12 |
| 2014-10-31 | 42.93M shares 10-Q · filed 2014-11-12 |
| 2014-07-31 | 42.92M shares 10-Q · filed 2014-08-12 |
| 2014-04-30 | 42.05M shares 10-Q · filed 2014-05-13 |
| 2014-03-14 | 42.04M shares 10-K · filed 2014-03-21 |
| 2013-11-08 | 33.84M shares 10-Q · filed 2013-11-13 |
| 2013-07-31 | 30.94M shares 10-Q · filed 2013-08-14 |
| 2013-05-10 | 30.99M shares 10-Q · filed 2013-05-15 |
| 2013-02-28 | 30.89M shares 10-K · filed 2013-03-15 |
| 2012-10-31 | 24.53M shares 10-Q · filed 2012-11-02 |
| 2012-07-31 | 24.46M shares 10-Q · filed 2012-08-13 |
| 2012-05-31 | 24.38M shares 10-Q · filed 2012-06-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |